![](/img/cover-not-exists.png)
Preclinical anticancer efficacy of BET bromodomain inhibitors is determined by the apoptotic response
Conery, A. R., Centore, R. C., Spillane, K. L., Follmer, N. E., Bommi-Reddy, A., Hatton, C., Bryant, B. M., Greninger, P., Amzallag, A., Benes, C. H., Mertz, J. A., Sims, R. J.Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-15-1458
Date:
January, 2016
File:
PDF, 886 KB
english, 2016